Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A17147 | 27957247 | World J Hepatol | Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease research. | 2016 | Details |
A17148 | 27957244 | World J Hepatol | Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease. | 2016 | Details |
A17149 | 27957239 | Oxid Med Cell Longev | Oxidative Stress and Liver Cancer: Etiology and Therapeutic Targets. | 2016 | Details |
A17150 | 27956809 | World J Gastroenterol | Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. | 2016 | Details |
A17151 | 27956794 | World J Gastroenterol | Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. | 2016 | Details |
A17152 | 27956792 | World J Gastroenterol | Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. | 2016 | Details |
A17153 | 27956256 | Clin Res Hepatol Gastroenterol | Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver disease. | 2016 | Details |
A17154 | 27956025 | Nutr Metab Cardiovasc Dis | Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors. | 2016 | Details |
A17155 | 27955646 | Nutr J | Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: a cross-sectional study. | 2016 | Details |
A17156 | 27955628 | BMC Gastroenterol | Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma. | 2016 | Details |
A17157 | 27942596 | JCI Insight | Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. | 2016 | Details |
A17158 | 27941940 | Nutr Diabetes | Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway. | 2016 | Details |
A17159 | 27941355 | Curr Opin Infect Dis | Managing nonalcoholic fatty liver disease in patients living with HIV. | 2017 | Details |
A17160 | 27939923 | Dig Liver Dis | CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice. | 2016 | Details |
A17161 | 27939613 | Toxicol In Vitro | Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. | 2016 | Details |
A17162 | 27939359 | Pharmacol Res | A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug? | 2016 | Details |
A17163 | 27938563 | Zhonghua Gan Zang Bing Za Zhi | [Effect of nicotinic acetylcholine receptor α7 subunit gene on liver inflammatory reaction in mice with nonalcoholic steatohepatitis and related mechanisms]. | 2016 | Details |
A17164 | 27938560 | Zhonghua Gan Zang Bing Za Zhi | [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats]. | 2016 | Details |
A17165 | 27937040 | Expert Rev Gastroenterol Hepatol | Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era. | 2016 | Details |
A17166 | 27936481 | Z Gastroenterol | Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk. | 2016 | Details |
A17167 | 27936280 | J Gastroenterol Hepatol | Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease. | 2017 | Details |
A17168 | 27936230 | PLoS One | The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients. | 2016 | Details |
A17169 | 27936091 | PLoS One | Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms. | 2016 | Details |
A17170 | 27935258 | Mol Nutr Food Res | Polyphenols from Lonicera caerulea L. berry attenuate experimental nonalcoholic steatohepatitis by inhibiting proinflammatory cytokines productions and lipid peroxidation. | 2017 | Details |
A17172 | 27935134 | Cell Biochem Funct | Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis. | 2016 | Details |
A17173 | 27933201 | BMJ Open Gastroenterol | Association between metabolic syndrome and liver histology among NAFLD patients without diabetes. | 2016 | Details |
A17175 | 27930988 | Biomed Pharmacother | Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD: Accuracy of non- invasive panel in determining the stage of liver fibrosis in rats. | 2016 | Details |
A17176 | 27930747 | PLoS One | Correction: Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
A17177 | 27929200 | Thromb Haemost | Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans. | 2016 | Details |
A17178 | 27928909 | Proteomics | Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model. | 2017 | Details |
A17179 | 27928661 | J Bone Miner Metab | Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis. | 2016 | Details |
A17180 | 27927668 | BMJ Open | Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study. | 2016 | Details |
A17181 | 27925353 | Hepatol Res | Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus. | 2016 | Details |
A17182 | 27924915 | Sci Rep | Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. | 2016 | Details |
A17184 | 27923447 | Metabolism | Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. | 2016 | Details |
A17185 | 27923446 | Metabolism | Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status. | 2016 | Details |
A17186 | 27922486 | Eur J Gastroenterol Hepatol | The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study. | 2017 | Details |
A17187 | 27922112 | Sci Rep | Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention. | 2016 | Details |
A17188 | 27921044 | Visc Med | Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome. | 2016 | Details |
A17189 | 27920819 | Res Pharm Sci | Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver. | 2016 | Details |
A17190 | 27920470 | World J Gastroenterol | Nonalcoholic fatty liver disease - A multisystem disease? | 2016 | Details |
A17191 | 27919360 | J Clin Lipidol | Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study. | 2016 | Details |
A17192 | 27919310 | J Dev Orig Health Dis | Indicators of fetal growth and adult liver enzymes: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. | 2016 | Details |
A17196 | 27917591 | Diabetes Obes Metab | The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism. | 2017 | Details |
A17197 | 27917585 | Liver Int | The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease. | 2016 | Details |
A17198 | 27917557 | Hepatol Res | Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus. | 2016 | Details |
A17199 | 27917437 | Cell Tissue Res | Nicotine plus a high-fat diet triggers cardiomyocyte apoptosis. | 2016 | Details |
A17200 | 27916988 | Int J Obes (Lond) | Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls. | 2016 | Details |
A17201 | 27916783 | Endocr J | Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial. | 2016 | Details |
A17202 | 27916647 | Biochimie | PPARs and nonalcoholic fatty liver disease. | 2016 | Details |
A17203 | 27916420 | Biomed Pharmacother | Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress. | 2016 | Details |
A17204 | 27914698 | Nutr Metab Cardiovasc Dis | Under-prescription of statins in patients with non-alcoholic fatty liver disease. | 2016 | Details |
A17206 | 27914137 | J Korean Med Sci | Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty Liver Disease?: a Cross-Sectional Study of the Healthy Population. | 2017 | Details |
A17207 | 27914133 | J Korean Med Sci | Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness. | 2017 | Details |
A17208 | 27913996 | Dig Dis Sci | Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models. | 2016 | Details |
A17209 | 27913605 | Eur J Endocrinol | Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. | 2017 | Details |
A17210 | 27913210 | Free Radic Biol Med | TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity. | 2016 | Details |
A17211 | 27911810 | Proc Natl Acad Sci U S A | In vivo bioluminescence imaging reveals copper deficiency in a murine model of nonalcoholic fatty liver disease. | 2016 | Details |
A17212 | 27911262 | Gastroenterology | Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A17213 | 27910784 | Int J Med Mushrooms | Hepatoprotective Effect of Tricholoma giganteum (Agaricomycetes) in a Nonalcoholic Fatty Liver Disease Rat Model. | 2016 | Details |
A17214 | 27909908 | Recent Results Cancer Res | Obesity and Liver Cancer. | 2017 | Details |
A17215 | 27909723 | Mol Med Rep | Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease. | 2016 | Details |
A17216 | 27908750 | Transl Res | Mesenchymal stromal cell-based therapies reduce obesity and metabolic syndromes induced by a high-fat diet. | 2016 | Details |
A17217 | 27908430 | J Trace Elem Med Biol | Evaluation of tissue metal and trace element content in a rat model of non-alcoholic fatty liver disease using ICP-DRC-MS. | 2016 | Details |
A17218 | 27908400 | J Trace Elem Med Biol | Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome. | 2016 | Details |
A17219 | 27907824 | J Nutr Biochem | Effect of dry tomato peel supplementation on glucose tolerance, insulin resistance, and hepatic markers in mice fed high-saturated-fat/high-cholesterol diets. | 2016 | Details |
A17220 | 27906700 | Curr Opin Clin Nutr Metab Care | Update on lipid species and paediatric nonalcoholic fatty liver disease. | 2017 | Details |
A17221 | 27906428 | Eur Rev Med Pharmacol Sci | The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. | 2016 | Details |
A17222 | 27905898 | BMC Med Genet | Physical activity and sedentary behavior can modulate the effect of the PNPLA3 variant on childhood NAFLD: a case-control study in a Chinese population. | 2016 | Details |
A17223 | 27904677 | Am J Transl Res | An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function. | 2016 | Details |
A17224 | 27904598 | J Res Med Sci | The effects of low carbohydrate diets on liver function tests in nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials. | 2016 | Details |
A17225 | 27903831 | J Nutr | Dietary Mung Bean Protein Reduces Hepatic Steatosis, Fibrosis, and Inflammation in Male Mice with Diet-Induced, Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A17226 | 27903585 | Am J Physiol Cell Physiol | Autophagy in chronic liver diseases: the two faces of Janus. | 2016 | Details |
A17227 | 27901086 | Sci Rep | Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway. | 2016 | Details |
A17228 | 27899914 | Front Endocrinol (Lausanne) | How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease? | 2016 | Details |
A17229 | 27899042 | Int J Food Sci Nutr | Hepatic rhythmicity of endoplasmic reticulum stress is disrupted in perinatal and adult mice models of high-fat diet-induced obesity. | 2016 | Details |
A17230 | 30556967 | Nurs N Z | Diseases of the Liver. | 2016 | Details |
A17231 | 27898698 | PLoS One | Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice. | 2016 | Details |
A17233 | 27896396 | Anal Bioanal Chem | Metabolic profiling of ob/ob mouse fatty liver using HR-MAS 1H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway. | 2016 | Details |
A17234 | 27895822 | World J Diabetes | Linagliptin alleviates fatty liver disease in diabetic db/db mice. | 2016 | Details |
A17235 | 27895587 | Front Physiol | Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models. | 2016 | Details |
A17236 | 27895422 | World J Gastroenterol | Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease. | 2016 | Details |
A17237 | 27895397 | World J Gastroenterol | Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. | 2016 | Details |
A17238 | 27895393 | World J Gastroenterol | Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease. | 2016 | Details |
A17239 | 27895389 | J Clin Biochem Nutr | Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus. | 2016 | Details |
A17240 | 27894410 | Cell Mol Biol (Noisy-le-grand) | Association of HFE gene mutations with nonalcoholic fatty liver disease in the Iranian population. | 2016 | Details |
A17241 | 27893783 | PLoS One | Role of PTEN in Oxidative Stress and DNA Damage in the Liver of Whole-Body Pten Haplodeficient Mice. | 2016 | Details |
A17242 | 27893763 | PLoS One | The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. | 2016 | Details |
A17243 | 27891768 | Liver Int | Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis. | 2016 | Details |
A17244 | 27891168 | Nutr Metab (Lond) | Erratum to: Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study). | 2016 | Details |
A17245 | 27891128 | Front Immunol | Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. | 2016 | Details |
A17246 | 27890642 | Free Radic Biol Med | Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. | 2016 | Details |
A17247 | 27890486 | Clin Nutr | Towards a multidisciplinary approach to understand and manage obesity and related diseases. | 2016 | Details |
A17248 | 27889947 | Hepatol Res | Pathological Findings of NASH and NAFLD: for Guidebook of NASH and NAFLD, 2015: The Japan Society of Hepatology. | 2017 | Details |
A17249 | 27889912 | Acta Paediatr | Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents. | 2017 | Details |
A17250 | 27889809 | Diabetologia | Reversal of type 2 diabetes in youth who adhere to a very-low-energy diet: a pilot study. | 2016 | Details |
A17251 | 27889747 | Cell Physiol Biochem | Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. | 2016 | Details |
A17252 | 27889599 | J Affect Disord | Patatin-like phospholipase domain-containing protein 3 (PNPLA3): A potential role in the association between liver disease and bipolar disorder. | 2016 | Details |
A17253 | 27889576 | Gastroenterology | Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. | 2016 | Details |
A17254 | 27889556 | Int Immunopharmacol | Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiation. | 2016 | Details |